跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACNATAC clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube - TGA Drug Approval Details
Approvals
/
TGA
/
ACNATAC clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube
Approved
STANDARD
ACNATAC clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
20c4b61d114e446b
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
20c4b61d114e446b
Product Name
ACNATAC clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube
Artg Id
232394
Artg Name
ACNATAC clindamycin (as phosphate) 1.0% w/w and tretinoin 0.025% w/w topical gel, tube
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
2016-03-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0dc864c6e43e30a3b5ec234744f2f5cc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6cda9693bf0d74e9be16f067d17a76bd.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
20c4b61d114e446b
Type
Standard
Back to TGA Approvals